Crucial role of calbindin-D 28k in the pathogenesis of Alzheimer's disease mouse model

Cell Death and Differentiation

Volumn 21, Issue 10, 2014, Pages 1575-1587

  Kook, S Y ^a   Jeong, H ^b   Kang, M J ^c   Park, R ^a   Shin, H J ^a   Han, S H ^a   Son, S M ^a   Song, H ^a   Baik, S H ^a   Moon, M ^d   Yi, E C ^c   Hwang, D ^b,e   Mook Jung, I ^a  

^a Seoul National University   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c Seoul National University   (South Korea)

^d MCLEAN HOSPITAL   (United States)

^e Institute for Basic Science   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALBINDIN 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DLGH4 PROTEIN, MOUSE; GUANYLATE KINASE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N-METHYL D-ASPARTATE RECEPTOR SUBTYPE 2A; NMDA RECEPTOR A1; SYNAPTOPHYSIN; SYP PROTEIN, MOUSE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL; APOPTOSIS; DISEASE MODEL; FEMALE; GENETICS; HIPPOCAMPUS; KNOCKOUT MOUSE; METABOLISM; MITOCHONDRION; MOUSE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOPTOSIS; CALBINDIN 1; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GUANYLATE KINASE; HIPPOCAMPUS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MITOCHONDRIA; PLAQUE, AMYLOID; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; SYNAPTOPHYSIN;

EID: 84900900364     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.67     Document Type: Article

References (59)

1. Nagy Z, Esiri MM, Joachim C, Jobst KA, Morris JH, King EM et al. Comparison of pathological diagnostic criteria for Alzheimer disease. Alzheimer Dis Assoc Disord 1998; 12: 182-189.
2. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-356.
3. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 2001; 21: 3017-3023.
4. Palotas A, Kalman J, Palotas M, Juhasz A, Janka Z, Penke B. Fibroblasts and lymphocytes from Alzheimer patients are resistant to beta-amyloid-induced increase in the intracellular calcium concentration. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 971-974.
5. Foster TC, Kumar A. Calcium dysregulation in the aging brain. Neuroscientist 2002; 8: 297-301.
6. Heizmann CW, Braun K. Changes in Ca(2\+)-binding proteins in human neurodegenerative disorders. Trends Neurosci 1992; 15: 259-264.
7. Baimbridge KG, Celio MR, Rogers JH. Calcium-binding proteins in the nervous system. Trends Neurosci 1992; 15: 303-308.
8. Guo Q, Christakos S, Robinson N, Mattson MP. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. Proc Natl Acad Sci USA 1998; 95: 3227-3232.
9. Wernyj RP, Mattson MP, Christakos S. Expression of calbindin-D28k in C6 glial cells stabilizes intracellular calcium levels and protects against apoptosis induced by calcium ionophore and amyloid beta-peptide. Brain Res Mol Brain Res 1999; 64: 69-79.
10. Jung EM, An BS, Choi KC, Jeung EB. Apoptosis-and endoplasmic reticulum stress-related genes were regulated by estrogen and progesterone in the uteri of calbindin-D(9k) and-D(28k) knockout mice. J Cell Biochem 2012; 113: 194-203.
11. Palop JJ, Jones B, Kekonius L, Chin J, Yu GQ, Raber J et al. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's diseaserelated cognitive deficits. Proc Natl Acad Sci USA 2003; 100: 9572-9577.
12. Airaksinen MS, Eilers J, Garaschuk O, Thoenen H, Konnerth A, Meyer M. Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28k gene. Proc Natl Acad Sci USA 1997; 94: 1488-1493.
13. Farre-Castany MA, Schwaller B, Gregory P, Barski J, Mariethoz C, Eriksson JL et al. Differences in locomotor behavior revealed in mice deficient for the calcium-binding proteins parvalbumin, calbindin D-28k or both. Behav Brain Res 2007; 178: 250-261.
14. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 2006; 26: 10129-10140.
15. Iritani S, Niizato K, Emson PC. Relationship of calbindin D28K-immunoreactive cells and neuropathological changes in the hippocampal formation of Alzheimer's disease. Neuropathology 2001; 21: 162-167.
16. Moon M, Hong HS, Nam DW, Baik SH, Song H, Kook SY et al. Intracellular amyloid-beta accumulation in calcium-binding protein-deficient neurons leads to amyloid-beta plaque formation in animal model of Alzheimer's disease. J Alzheimer's Dis 2012; 29: 615-628.
17. Janus C, Westaway D. Transgenic mouse models of Alzheimer's disease. Physiol Behav 2001; 73: 873-886.
18. Kobayashi DT, Chen KS. Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease. Genes Brain Behav 2005; 4: 173-196.
19. Sutherland MK, Somerville MJ, Yoong LK, Bergeron C, Haussler MR, McLachlan DR. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res 1992; 13: 239-250.
20. Dowd DR, MacDonald PN, Komm BS, Haussler MR, Miesfeld RL. Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes. Mol Endocrinol 1992; 6: 1843-1848.
21. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 2001; 1: 515-525.
22. Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB et al. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging 2006; 27: 1564-1576.
23. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2009; 106: 14670-14675.
24. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004; 116: 205-219.
25. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004; 287: C817-C833.
26. Cha MY, Han SH, Son SM, Hong HS, Choi YJ, Byun J et al. Mitochondria-specific accumulation of amyloid beta induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One 2012; 7: e34929.
27. Blass JP, Sheu RK, Gibson GE. Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. Ann N Y Acad Sci 2000; 903: 204-221.
28. Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum Mol Genet 2011; 20: 4515-4529.
29. Ghosh A, Greenberg ME. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 1995; 268: 239-247.
30. Yamin G. NMDA receptor-dependent signaling pathways that underlie amyloid betaprotein disruption of LTP in the hippocampus. J Neurosci Res 2009; 87: 1729-1736.
31. Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361: 31-39.
32. Molinari S, Battini R, Ferrari S, Pozzi L, Killcross AS, Robbins TW et al. Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression. Proc Natl Acad Sci USA 1996; 93: 8028-8033.
33. Adams JP, Sweatt JD. Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol 2002; 42: 135-163.
34. Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 1999; 68: 821-861.
35. Pasti L, Carmignoto G, Pozzan T, Battini R, Ferrari S, Lally G et al. Cellular calcium handling in brain slices from calbindin D28k-deficient mice. Neuroreport 1999; 10: 2367-2372.
36. Greene JR, Radenahmad N, Wilcock GK, Neal JW, Pearson RC. Accumulation of calbindin in cortical pyramidal cells with ageing; a putative protective mechanism which fails in Alzheimer's disease. Neuropathol Appl Neurobiol 2001; 27: 339-342.
37. Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 2006; 63: 693-699.
38. Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Mannella CA et al. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2002; 2: 55-67.
39. Youle RJ, Karbowski M. Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol 2005; 6: 657-663.
40. Benard G, Bellance N, James D, Parrone P, Fernandez H, Letellier T et al. Mitochondrial bioenergetics and structural network organization. J Cell Sci 2007; 120(Pt 5): 838-848.
41. Costa V, Giacomello M, Hudec R, Lopreiato R, Ermak G, Lim D et al. Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli. EMBO Mol Med 2010; 2: 490-503.
42. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 1992; 258: 597-603.
43. Fukunaga K, Miyamoto E. Role of MAP kinase in neurons. Mol Neurobiol 1998; 16: 79-95.
44. Bading H, Greenberg ME. Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science 1991; 253: 912-914.
45. Li Z, Okamoto K, Hayashi Y, Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004; 119: 873-887.
46. Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Graber S et al. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 2006; 25: 3900-3911.
47. Pozueta J, Lefort R, Shelanski ML. Synaptic changes in Alzheimer's disease and its models. Neuroscience 2012; 251: 51-65.
48. Kim JH, Lee JA, Song YM, Park CH, Hwang SJ, Kim YS et al. Overexpression of calbindin-D28K in hippocampal progenitor cells increases neuronal differentiation and neurite outgrowth. FASEB J 2006; 20: 109-111.
49. Bellido T, Huening M, Raval-Pandya M, Manolagas SC, Christakos S. Calbindin-D28k is expressed in osteoblastic cells and suppresses their apoptosis by inhibiting caspase-3 activity. J Biol Chem 2000; 275: 26328-26332.
50. D'Amelio M, Cavallucci V, Middei S, Marchetti C, Pacioni S, Ferri A et al. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat Neurosci 2011; 14: 69-76.
51. Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL et al. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Eur J Neurosci 2006; 23: 251-260.
52. Quackenbush J. Microarray data normalization and transformation. Nat Genet 2002; 32(Suppl): 496-501.
53. Chae S, Ahn BY, Byun K, Cho YM, Yu MH, Lee B et al. A systems approach for decoding mitochondrial retrograde signaling pathways. Sci Signal 2013; 6: rs4.
54. Hwang D, Rust AG, Ramsey S, Smith JJ, Leslie DM, Weston AD et al. A data integration methodology for systems biology. Proc Natl Acad Sci USA 2005; 102: 17296-17301.
55. Rosenfeld J, Capdevielle J, Guillemot JC, Ferrara P. In-gel digestion of proteins for internal sequence analysis after one-or two-dimensional gel electrophoresis. Anal Biochem 1992; 203: 173-179.
56. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002; 74: 5383-5392.
57. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003; 75: 4646-4658.
58. Fu X, Gharib SA, Green PS, Aitken ML, Frazer DA, Park DR et al. Spectral index for assessment of differential protein expression in shotgun proteomics. J Proteome Res 2008; 7: 845-854.
59. Ekins S, Nikolsky Y, Bugrim A, Kirillov E, Nikolskaya T. Pathway mapping tools for analysis of high content data. Methods Mol Biol 2007; 356: 319-350.